UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 11, 2016
Accession Number: 0001193125-15-412974
Submission Type: POS AM
CIK: 0001588972
Company Name: Recro Pharma, Inc.
File Number: 333-201841